Asthma
-
Understanding the importance of particle size and delivery system
Industry Supported
|
Small airway disease (SAD) may be a treatable trait, alongside other comorbidities such as gastroesophageal reflux, rhinosinusitis, and obesity. Experts discuss optimal management of SAD, including small particle delivery.
-
Triple therapy shows meaningful benefits in uncontrolled asthma
Alberto Papi, MD, FCCP, said recent data from the KALOS and LOGOS trials suggest triple therapy may address airflow limitation and exacerbation risk in a single inhaler.
-
Biologic therapies in asthma: From foundation to the future
Biologic therapies are changing severe asthma management, shifting the goal from control to remission. Diego J. Maselli, MD, FCCP; Dharani Narendra, MD, FCCP; and Megan Conroy, MD, MAEd, FCCP, explore their impact in this installment of Clinical Outlook in Pulmonology.
-
GLP-1RAs may reduce risk of asthma exacerbations for adolescents with obesity
Pulmonologist Farrukh Abbas, MD, said this observational study generates a hypothesis about the anti-inflammatory benefits of GLP1-RA medications in patients with asthma and obesity that needs to be confirmed in trials.
-
The climate cost of inhalers: What prescribers should know
Experts said clinicians must ensure patients have the therapies they need at affordable prices that, ideally, impose minimal amounts of environmental harm.
-
Panelists address local approaches for clean air and climate action
Stephanie Lovinsky-Desir, MD, MS, presented on the health effects and mitigation of pollutant exposures at or near schools.
-
Clinicians share advice for working with vulnerable patient populations
Laura J. Spece, MD, MSc, spoke about specific respiratory health concerns for US military veterans during a session that also focused on optimizing care for patients who are transgender, patients shifting from pediatric to adult care, and patients with limited language proficiency.
-
Panel to explore how age, hormones, and other factors impact severe asthma
Amik Sodhi, MBBS, FCCP, will present during a Monday morning session on severe asthma across the lifespan, including the impact of hormones and major life events marked by hormonal changes.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Session to present key allergy insights that asthma clinicians need to know
S. Shahzad Mustafa, MD, will chair a Sunday morning session that will highlight significant overlap between asthma and allergic conditions, particularly allergic rhinitis and chronic sinusitis with nasal polyposis.
-
Panel to explore considerations for biologic therapy in severe asthma
Sara Assaf, MD, will chair a session examining key challenges and strategies for selecting the right biologic therapy for patients with severe asthma.
